Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hampe

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Gut|April 15, 2004
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel diseaseS J Ott, M Musfeldt, D F Wenderoth, et al.
The EMBO Journal|June 3, 2000
The conserved phosphoinositide 3-kinase pathway determines heart size in miceT Shioi, P M Kang, P S Douglas, et al.
Forensic Science International|May 1, 1993
Paternity testing with oligonucleotide multilocus probe (CAC)5/(GTG)5: a multicenter studyM Krawczak, I Böhm, P Nürnberg, et al.
EXS|January 1, 1993
Oligonucleotide DNA fingerprinting: results of a multi-center study on reliability and validityI Böhm, M Krawczak, P Nürnberg, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 24, 2006
Association between functional FABP2 promoter haplotype and type 2 diabetesY Li, E Fisher, M Klapper, et al.
Gut|August 13, 2002
Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel diseaseS Schreiber, P Rosenstiel, J Hampe, et al.
Genes and Immunity|February 16, 2007
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitisT H Karlsen, K M Boberg, M Vatn, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 26, 2014
Does neoadjuvant treatment before oncologic esophagectomy affect the postoperative quality of life? A prospective, longitudinal outcome studyC Hauser, C Patett, W von Schoenfels, et al.
Gastroenterology|May 9, 2007
No association between the TUCAN (CARD8) Cys10Stop mutation and inflammatory bowel disease in a large retrospective German and a clinically well-characterized Norwegian sampleA Franke, P Rosenstiel, T Balschun, et al.
Oncogene|September 8, 2009
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)A Arlt, I Bauer, C Schafmayer, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Gut|April 15, 2004
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel diseaseS J Ott, M Musfeldt, D F Wenderoth, et al.
The EMBO Journal|June 3, 2000
The conserved phosphoinositide 3-kinase pathway determines heart size in miceT Shioi, P M Kang, P S Douglas, et al.
Forensic Science International|May 1, 1993
Paternity testing with oligonucleotide multilocus probe (CAC)5/(GTG)5: a multicenter studyM Krawczak, I Böhm, P Nürnberg, et al.
EXS|January 1, 1993
Oligonucleotide DNA fingerprinting: results of a multi-center study on reliability and validityI Böhm, M Krawczak, P Nürnberg, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 24, 2006
Association between functional FABP2 promoter haplotype and type 2 diabetesY Li, E Fisher, M Klapper, et al.
Gut|August 13, 2002
Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel diseaseS Schreiber, P Rosenstiel, J Hampe, et al.
Genes and Immunity|February 16, 2007
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitisT H Karlsen, K M Boberg, M Vatn, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 26, 2014
Does neoadjuvant treatment before oncologic esophagectomy affect the postoperative quality of life? A prospective, longitudinal outcome studyC Hauser, C Patett, W von Schoenfels, et al.
Gastroenterology|May 9, 2007
No association between the TUCAN (CARD8) Cys10Stop mutation and inflammatory bowel disease in a large retrospective German and a clinically well-characterized Norwegian sampleA Franke, P Rosenstiel, T Balschun, et al.
Oncogene|September 8, 2009
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)A Arlt, I Bauer, C Schafmayer, et al.
Pageof 7